ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma.

Dongjian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.